Children affected by rare cancers are often excluded from genomics research due to concerns about genetic discrimination. Read about our project on genetic discrimination that embodies values of equity and human rights, central to our mission.
Link: https://t.co/KRZCngpi2S
Meet Victoria Forster, Co-Lead, Psychosocial & Survivorship.
She is a Person With Lived Experience and was named on the Forbes 30 under 30, a 2017 TED Global fellow, and consults on science communication and patient engagement in research.
More: https://t.co/ZWqJTsXLyG
Curious what projects are currently underway at ACCESS?
Here's a sneak peak to some projects videos https://t.co/bp8oqERbLO and a presentation deck https://t.co/j5G1NPBXcw
#PediatricCancer#ACCESSForAll
Meet Karan Haas, Co-Lead, Knowledge Mobilization Group.
Her son was diagnosed with a rare malignant brain tumor when 2.5 years old. She is interested in understanding molecular pathology to help patients and families better understand the disease.
More https://t.co/3lYxM440Sy
At ACCESS, equity, diversity, and inclusion are not just principles - they are fundamental to our purpose, mission, and every aspect of our work.
Read Our Story here: https://t.co/1AWNKpw2h7
#ACESSForAll
Researchers at CIHR-supported @acces_access are creating a database to help pediatric oncologists access innovative therapies for children with hard-to-cure cancers, ensuring every child in Canada can benefit from the latest advancements in cancer care.
https://t.co/L9J9s3D7kf
Des chercheurs du réseau @acces_access élaborent une base de données qui aidera les oncopédiatres du Canada à faire profiter tous les enfants touchés par un cancer, y compris par une forme difficile à traiter, des dernières avancées scientifiques.
https://t.co/v26MsCdtsd
Radiation remains an important treatment for pediatric cancer patients. A team at the CIHR-supported @acces_access network is studying the benefits and side effects of proton and photon radiation therapy.
https://t.co/JwYy5FqPLM
La radiothérapie demeure l’un des principaux traitements prodigués aux enfants touchés par le cancer. Une équipe du réseau @acces_access, que soutiennent les IRSC, examine les avantages et les inconvénients de la protonthérapie et de la photonthérapie.
https://t.co/QRMQoqxuBQ
Every year, over 400,000 children worldwide are diagnosed with cancer, including 1,500 cases in Canada.
This is why ACCESS employs a community-driven, networked approach to tackling pediatric cancers
Learn more our work: https://t.co/aMsLUtwzNV
#InternationalChildhoodCancerDay
Over 400,000 children worldwide are diagnosed with cancer, including 1,500 cases in Canada.
On #InternationalChildhoodCancerDay, we reaffirm our commitment to improving equitable access to research and care for children and their families.
https://t.co/RM7UPqrvg2
Chaque année, le cancer est diagnostiqué chez 1 500 enfants et adolescents au Canada. Le réseau @acces_access met la recherche au service de leur santé et de l’équité d’accès à des soins de qualité.
#JourneeInternationaleDuCancerDeLEnfant
https://t.co/s1AM5CJiD3
Every year, approximately 1,500 children are diagnosed with cancer in Canada. The CIHR-supported @acces_access network is advancing research to improve outcomes and ensure equitable cancer care for children and youth.
#InternationalChildhoodCancerDay
https://t.co/47pQN3SXE0
It's International Day of Women and Girls in Science. 🧪
Let's honour their achievements and commit to building a future where every girl can dream, discover, and thrive in science. 🌟
#InternationalDayofWomenandGirlsinScience#BreakTheBarriers
Today is World Cancer Day.
At ACCESS, we stand united to raise awareness, show support, and advocate for a future where every child diagnosed with cancer in Canada receives equitable access to the care they need and deserve.
Read our story:https://t.co/I0zhhJzYwh
#WorldCancerDay
Meet Sonia Cellot, Co-Lead, Cancer Biology.
Her research focuses on understanding how blood-forming stem cells work and creating synthetic models to identify weaknesses in pediatric leukemia to find better treatment options.
More: https://t.co/W7jhHWmACh
#MeetTheACCESSNetwork
Diya Uberoi, Academic Associate of Centre of Genomics and Policy (CGP) and Associate Director of Genetic Discrimination Observatory (GDO), presented the GDO's most recent project on #GeneticDiscrimination in #pediatric#oncology at @acces_access's Annual Conference 🩺 🧬